Abstract
You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology I1 Apr 2017MP39-06 WHOLE GENOME TRANSCRIPTIONAL ANALYSIS OF CLEAR CELL RENAL CELL CARCINOMA WITH VENOUS TUMOR THROMBUS REVEALS INTRATUMORAL HETEROGENEITY AND GENES ASSOCIATED WITH POOR OUTCOME Dharam Kaushik, Wasim Chowdhury, Ping Wu, Teresa Johnson-Pais, Yidong Chen, Michael A. Liss, and Ronald Rodriguez Dharam KaushikDharam Kaushik More articles by this author , Wasim ChowdhuryWasim Chowdhury More articles by this author , Ping WuPing Wu More articles by this author , Teresa Johnson-PaisTeresa Johnson-Pais More articles by this author , Yidong ChenYidong Chen More articles by this author , Michael A. LissMichael A. Liss More articles by this author , and Ronald RodriguezRonald Rodriguez More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1180AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Overall, 4 to 10% of newly diagnosed renal cell carcinoma (RCC) patients have been found to have a venous tumor thrombus (VTT). Intratumoral heterogeneity may contribute to progression of the disease and metastases. Previous studies have focused on studying the heterogeneity of metastases, recurrence and tumor. There has been no study to date evaluating VTT and characterizing its transcriptional profile. We report results of the transcriptional analysis of primary tumor (PT), VTT and adjacent normal parenchyma (NP). METHODS We performed Whole Transcriptome Sequencing on fresh tissue specimens from 6 patients with clear cell RCC and VTT collected at the time of radical nephrectomy with tumor thrombectomy. We evaluated transcriptional alterations between PT/NP, VTT/NP and VTT/PT. We compared our data set with The Cancer Genome Atlas (TCGA) data. For multiple testing corrections, we utilized false discovery estimation and differential expression criterion. RESULTS 1. We surveyed 23,228 genes and identified differential expression in 1455, 1344 and 26 genes between tumor and normal parenchyma (PT/NP), tumor thrombus and normal parenchyma (VTT/NP) and tumor thrombus and primary tumor (VTT/PT) respectively. We identified altered key pathways (cytokine activity, regulation of apoptosis, cytoskeleton organization, immune response). 2. We compared these genes with TCGA data and identified 35 genes, which predicted poor outcome. 3. VTT demonstrated statistically significant differential expression of OSM (2.37 fold), INHBA (1.9 fold), CCL2 (2.3 fold), CCL20 (2.9 fold) and IL1B genes (4.5 fold) compared to primary tumor (TT/T), (Figure1). 4. We identified statistically significant higher expression of OSM, INHBA, CCL20, and IL1B genes in higher tumor thrombus level compared to lower tumor thrombus level. CONCLUSIONS RNA sequencing of RCC with VTT reveals significant genomic intratumoral heterogeneity. We identified key molecular pathways and differential expression of genes in VTT compared to primary tumor (VTT/PT). Furthermore, these genes were found to be upregulated in higher VTT level compared to lower VTT level. These results will require validation in a larger cohort. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e495 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Dharam Kaushik More articles by this author Wasim Chowdhury More articles by this author Ping Wu More articles by this author Teresa Johnson-Pais More articles by this author Yidong Chen More articles by this author Michael A. Liss More articles by this author Ronald Rodriguez More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call